Current Treatment Options in Neurology

Papers
(The TQCC of Current Treatment Options in Neurology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Genetic Testing for Epilepsy: A User Guide61
Education and Team Science in Neurocritical Care51
Treatment of Symptomatic Carotid Webs: Current Evidence and Future Directions38
Should we Treat Sleep Apnoea to Prevent Dementia?34
Updates in the Management of Neuromuscular Emergencies29
Continuous EEG in Day to Day Neurocritical Care – A Case Based Review24
Tau in Multiple Sclerosis: A Review of Therapeutic Potential24
Speech Language Pathology in the Neurocritical Care Unit22
Ganaxolone for the Treatment of CDKL5 Disorder and Other Neurological and Psychiatric Conditions: A Review of the Clinical Trials16
Efficacy and Safety of Atogepant for Preventing Chronic and Episodic Migraines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials14
Prourokinase in Acute Ischemic Stroke: A Review of Current Evidence13
Correction to: Diagnosis and Management of Progressive Corticobasal Syndrome13
Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia11
Addressing the Burden of Pathological Fatigue in Stroke Survivors: A Review of Present and Potential Non-Pharmacological and Pharmacotherapeutic Options11
Treatment of Malignant Cerebral Edema in Acute Ischemic Stroke10
Updates in the Management of Cervical Artery Dissections8
Ocular Myasthenia Gravis7
Biomarker Defined Acute Optic Neuritis: A Review and Perspective7
Epilepsy Management in Transgender and Gender Diverse People6
Updates on Facioscapulohumeral Muscular Dystrophy (FSHD)6
Diagnosis and Treatment of Poststroke Epilepsy: Where Do We Stand?6
Managing the Behavioral and Psychological Symptoms of Dementia6
Management Strategies for Atypical Parkinsonism5
Treatment of Fever in Neurologically Critically Ill Patients5
Update on Stroke Prevention and Treatment in Patients with Antiphospholipid Antibody Syndrome5
Predicting and Treating Post-traumatic Epilepsy5
The A2F ICU Liberation Bundle in Neurocritical Care5
Sleep Neurophysiology and Psychiatric Disorders: a Transdiagnostic Framework for Mechanistic and Therapeutic Insight5
Headache as a Neurologic Manifestation of Systemic Disease5
Cerebral Venous Thrombosis: Medical Management vs. Endovascular Therapy4
Key Treatment Issues for Epilepsy in the Context of Autism Spectrum Disorder4
Update on Treatment of Idiopathic (and Non-Idiopathic) Orbital Inflammation4
Strategic De-escalation of Disease-Modifying Therapies in Elderly Patients: Approaches and Considerations4
Non-Cognitive Symptoms in Alzheimer’s Disease and Their Likely Impact on Patient Outcomes. A Scoping Review4
Treatment Approaches in Pediatric Relapsing Autoimmune Encephalitis4
Clinical Applications of Non-Invasive Brain Stimulation in Stroke Recovery: A Review of Current Evidence and Therapeutic Strategies4
Mechanical Thrombectomy for Acute Ischemic Stroke: Current State and Future Directions4
Diagnosis, Treatment, and Prevention of Stroke in Transgender Adults4
Approach to the Management of Sodium Disorders in the Neuro Critical Care Unit3
Distinguishing Benign Rashes From Severe Skin Reactions From Anti-Seizure Medications3
The Efficacy of Deep Brain Stimulation in the Treatment of Essential Tremor: A Systematic Review3
Current Endovascular Treatments in Neuro-Ophthalmology3
Vaccine Based Approaches for the Prevention and Treatment of Neurological Disease3
Update on Transient Global Amnesia (TGA): Current Theories Underlying the Etiology, Diagnosis, Prognosis, and Management of TGA3
Telestroke’s Role Through the COVID-19 Pandemic and Beyond3
Correction to: Acute Stroke Treatment in Children: Are Adult Guidelines Applicable?3
Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview3
Critical Illness Myopathy: Diagnostic Approach and Resulting Therapeutic Implications3
Seizures in the Setting of COVID-193
0.048501968383789